138 related articles for article (PubMed ID: 22433757)
1. Lifetime cost-effectiveness of skin cancer prevention through promotion of daily sunscreen use.
Hirst NG; Gordon LG; Scuffham PA; Green AC
Value Health; 2012; 15(2):261-8. PubMed ID: 22433757
[TBL] [Abstract][Full Text] [Related]
2. Cost-Effectiveness Analysis of a Skin Awareness Intervention for Early Detection of Skin Cancer Targeting Men Older Than 50 Years.
Gordon LG; Brynes J; Baade PD; Neale RE; Whiteman DC; Youl PH; Aitken JF; Janda M
Value Health; 2017 Apr; 20(4):593-601. PubMed ID: 28408001
[TBL] [Abstract][Full Text] [Related]
3. How many melanomas might be prevented if more people applied sunscreen regularly?
Olsen CM; Wilson LF; Green AC; Biswas N; Loyalka J; Whiteman DC
Br J Dermatol; 2018 Jan; 178(1):140-147. PubMed ID: 29239489
[TBL] [Abstract][Full Text] [Related]
4. Regular sunscreen use is a cost-effective approach to skin cancer prevention in subtropical settings.
Gordon LG; Scuffham PA; van der Pols JC; McBride P; Williams GM; Green AC
J Invest Dermatol; 2009 Dec; 129(12):2766-71. PubMed ID: 19536149
[TBL] [Abstract][Full Text] [Related]
5. Reduced melanoma after regular sunscreen use: randomized trial follow-up.
Green AC; Williams GM; Logan V; Strutton GM
J Clin Oncol; 2011 Jan; 29(3):257-63. PubMed ID: 21135266
[TBL] [Abstract][Full Text] [Related]
6. Prevention versus early detection for long-term control of melanoma and keratinocyte carcinomas: a cost-effectiveness modelling study.
Gordon L; Olsen C; Whiteman DC; Elliott TM; Janda M; Green A
BMJ Open; 2020 Feb; 10(2):e034388. PubMed ID: 32107270
[TBL] [Abstract][Full Text] [Related]
7. Estimated Healthcare Costs of Melanoma in Australia Over 3 Years Post-Diagnosis.
Elliott TM; Whiteman DC; Olsen CM; Gordon LG
Appl Health Econ Health Policy; 2017 Dec; 15(6):805-816. PubMed ID: 28756584
[TBL] [Abstract][Full Text] [Related]
8. Cost and clinical implications of diabetes prevention in an Australian setting: a long-term modeling analysis.
Palmer AJ; Tucker DM
Prim Care Diabetes; 2012 Jul; 6(2):109-21. PubMed ID: 22153888
[TBL] [Abstract][Full Text] [Related]
9. Daily sunscreen application and betacarotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: a randomised controlled trial.
Green A; Williams G; Neale R; Hart V; Leslie D; Parsons P; Marks GC; Gaffney P; Battistutta D; Frost C; Lang C; Russell A
Lancet; 1999 Aug; 354(9180):723-9. PubMed ID: 10475183
[TBL] [Abstract][Full Text] [Related]
10. Sunscreen and melanoma: is our prevention message correct?
Planta MB
J Am Board Fam Med; 2011; 24(6):735-9. PubMed ID: 22086817
[TBL] [Abstract][Full Text] [Related]
11. Health system costs of skin cancer and cost-effectiveness of skin cancer prevention and screening: a systematic review.
Gordon LG; Rowell D
Eur J Cancer Prev; 2015 Mar; 24(2):141-9. PubMed ID: 25089375
[TBL] [Abstract][Full Text] [Related]
12. Cutaneous malignant melanoma: facts about sunbeds and sunscreen.
Autier P
Expert Rev Anticancer Ther; 2005 Oct; 5(5):821-33. PubMed ID: 16221052
[TBL] [Abstract][Full Text] [Related]
13. Sunscreen and melanoma: what is the evidence?
Gimotty PA; Glanz K
J Clin Oncol; 2011 Jan; 29(3):249-50. PubMed ID: 21135278
[No Abstract] [Full Text] [Related]
14. The role of sunscreen preparations in preventing skin cancer.
Buchanan P
Prof Nurse; 2002 May; 17(9):558-60. PubMed ID: 12025019
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of apixaban compared to warfarin in the management of atrial fibrillation in Australia.
Ademi Z; Pasupathi K; Liew D
Eur J Prev Cardiol; 2015 Mar; 22(3):344-53. PubMed ID: 24281250
[TBL] [Abstract][Full Text] [Related]
16. Economic analysis of adjuvant interferon alfa-2b in high-risk melanoma based on projections from Eastern Cooperative Oncology Group 1684.
Hillner BE; Kirkwood JM; Atkins MB; Johnson ER; Smith TJ
J Clin Oncol; 1997 Jun; 15(6):2351-8. PubMed ID: 9196150
[TBL] [Abstract][Full Text] [Related]
17. Ipilimumab in 2nd line treatment of patients with advanced melanoma: a cost-effectiveness analysis.
Barzey V; Atkins MB; Garrison LP; Asukai Y; Kotapati S; Penrod JR
J Med Econ; 2013; 16(2):202-12. PubMed ID: 23057750
[TBL] [Abstract][Full Text] [Related]
18. Long-term increase in sunscreen use in an Australian community after a skin cancer prevention trial.
van der Pols JC; Williams GM; Neale RE; Clavarino A; Green AC
Prev Med; 2006 Mar; 42(3):171-6. PubMed ID: 16325898
[TBL] [Abstract][Full Text] [Related]
19. Long-term Cost-effectiveness of Statin Treatment for Primary Prevention of Cardiovascular Disease in the Elderly.
Lin L; Teng M; Zhao YJ; Khoo AL; Seet RC; Yong QW; Yeo TC; Lim BP
Cardiovasc Drugs Ther; 2015 Apr; 29(2):187-97. PubMed ID: 25860556
[TBL] [Abstract][Full Text] [Related]
20. Economic evaluation of skin cancer prevention in Australia.
Shih ST; Carter R; Sinclair C; Mihalopoulos C; Vos T
Prev Med; 2009 Nov; 49(5):449-53. PubMed ID: 19747936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
